Sangal Papers Limited announced the outcome of its Board of Directors meeting held on February 13, 2026, where the company approved unaudited financial results for Q3FY26 ended December 31, 2025. The paper manufacturing company reported strong quarterly performance with net profit surging 104% year-on-year despite facing some sequential challenges.

Board Meeting and Regulatory Compliance

The Board of Directors meeting commenced at 12:00 Noon and concluded at 01:15 P.M. on February 13, 2026. The board approved the unaudited financial statements for the quarter and nine months ended December 31, 2025, in compliance with Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Highlights

The company's financial metrics for Q3FY26 showed significant year-on-year improvement across key parameters:

Sequential Performance Analysis

While the year-on-year growth was impressive, the company experienced some sequential decline in Q3FY26 compared to Q2FY26:

Despite the revenue decline, the company managed to improve its net profit margin through better cost management and operational efficiency.

Nine-Month Performance Overview

For the nine months ended December 31, 2025, Sangal Papers showed mixed results compared to the corresponding period in the previous year:

Infrastructure Development Update

Sangal Papers provided an update on its infrastructure expansion project. The company is undertaking installation of a new 4.5 MW turbine to replace the existing 3 MW unit. According to the management, the erection and installation work is in process and is likely to be completed during the current month, provided all other factors are aligned with the timeline including receipt of materials.

Audit and Compliance Framework

The unaudited financial results were reviewed by the Audit Committee and approved by the Board of Directors. The statutory auditors RAJ VIYOM & CO. (Firm Registration No. 002011C) provided a limited review report in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company operates in a single segment of paper product manufacturing, making segment-wise disclosure under Ind AS 108 not applicable.

Sangal Papers Limited has announced its board meeting schedule to review the company's quarterly financial performance and approve key financial documents for the third quarter of fiscal year 2026.

Board Meeting Details

The company has scheduled its board of directors meeting for February 13, 2026, at 12:00 PM. The meeting will take place at the company's registered office located at Village Bhainsa, 22-km stone, Meerut-Mawana Road, Mawana, District Meerut, Uttar Pradesh - 250401.

Financial Results Review

The primary agenda of the board meeting includes consideration, approval and recording of the unaudited standalone financial results for the quarter ended December 31, 2025. The board will also address other matters as per the meeting agenda.

Trading Window Restrictions

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, Sangal Papers Limited has implemented trading window restrictions for designated persons. The trading window closure period extends from January 1, 2026, until 48 hours after the conclusion of the board meeting.

Corporate Communication

The notification was signed by Anant Vats, Company Secretary (FCS-5575), and communicated to the Bombay Stock Exchange Limited on January 31, 2026. The company maintains its listing on BSE under scrip code 516096.